HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Osteomyelitis of foot — Clinical Guidelines

Overview

Diabetic foot osteomyelitis (DFO) is a serious infection involving bone tissue in the foot of diabetic patients, often complicating neuropathic ulcers and leading to significant morbidity and potential amputation if not managed effectively.

Diagnosis

Clinical Presentation: Presence of neuropathic ulcer with exposed bone or suspicion of bone involvement 23.

Imaging: MRI is preferred over plain film radiography for better sensitivity and specificity 22 14.

Laboratory Tests: CRP and ESR can aid in monitoring treatment response but lack definitive diagnostic accuracy 3 16.

Culture Methods: Bone biopsy cultures are considered the gold standard, though ulcer swab cultures may lack concordance 4 24.

Advanced Diagnostics: Metagenomics next-generation sequencing (mNGS) shows promise as a complementary diagnostic tool 1 5.

Probe-to-Bone Test: Combined with ESR can enhance early diagnosis 12.

Management

Antibiotic Therapy: Duration varies; 6-week vs 12-week regimens show comparable outcomes in nonsurgical management 21.

Local Antibiotics: Use of antibiotic-impregnated bone substitutes like Cerament (G or V) may support healing but evidence is still emerging 2.

Surgical Interventions: Debridement and resection/curettage; no clear superiority between resection and curettage in healing times 6.

Conservative Surgery: Minimally invasive approaches can avoid amputation in selected cases 20.

Monitoring: ESR and CRP levels useful for monitoring treatment efficacy 16.

Specific Antibiotics: Rifampicin-ofloxacin regimen effective for mild to moderate cases 26.

Special Populations

Elderly: No specific guidelines provided in abstracts; management generally follows standard protocols with emphasis on conservative approaches to avoid amputation 20.

Comorbidities: Methicillin-resistant Staphylococcus aureus (MRSA) infections require tailored antibiotic regimens pre- and postoperatively 17.

Key Recommendations

Use MRI for guiding surgical extent in diabetic forefoot osteomyelitis to improve accuracy over plain radiography 14 (Evidence: Moderate).

Consider bone biopsy for definitive culture guidance despite its equivalence to ulcer swab cultures in some studies 4 24 (Evidence: Moderate).

Monitor treatment response with inflammatory markers like CRP and ESR, though they are not definitive diagnostic tools 3 16 (Evidence: Moderate).

Evaluate conservative surgical options to minimize amputation risk in carefully selected patients 20 (Evidence: Expert opinion).

Tailor antibiotic duration based on clinical response; 6-week regimens show efficacy in nonsurgical management 21 (Evidence: Moderate).

References

1 Schmidt BM, Ranjan P, Erb-Downward J, Dickson RP. Microbial Dominance in Diabetic Foot Osteomyelitis Determined With Nanopore Sequencing Techniques Predicts Positive Response to Surgical Intervention. The Journal of infectious diseases 2026. link 2 Elkady R, McHugh S, Kheirelseid E, Naughton P, Moneley D, Aly S et al.. The role of Cerament® (Antibiotic impregnated bone void filler) in lower limb salvage for diabetic foot patients with osteomyelitis, a scoping review. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland 2026. link 3 Liu L, Hou J, Tao Y, Zhou G, Xiao L, Li J et al.. Diagnostic accuracy of C-reactive protein for diabetic foot osteomyelitis: a retrospective study and meta-analysis of composite cut-off values. Journal of wound care 2026. link 4 Lagrand RS, Sabelis LWE, Gramberg MCTT, Ahmad M, van den Bosch AJF, Brekelmans W et al.. Bone Biopsy not Superior to Ulcer Bed Biopsy-guided Antibacterial Therapy on Remission of Diabetic Foot Osteomyelitis: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026. link 5 Morsli M, Magnan C, Salipante F, Dubois A, Schuldiner S, Cellier N et al.. Enhancing diabetic foot osteomyelitis diagnosis with metagenomics next-generation sequencing, proof of concept. Diabetic medicine : a journal of the British Diabetic Association 2026. link 6 Kmari-El-Ghazouany S, Tardáguila-García A, López-Moral M, García-Madrid M, García-Álvarez Y, Lázaro-Martínez JL. Comparative Analysis of Bone Resection Versus Bone Curettage in Diabetic Foot Osteomyelitis. The international journal of lower extremity wounds 2025. link 7 Panunzi A, Giurato L, Meloni M, Uccioli L. Bioactive Glass in a Multi Drug Resistance Osteomyelitis in Diabetic Foot: Case Report. The international journal of lower extremity wounds 2025. link 8 Aragón-Sánchez J, Víquez-Molina G, López-Valverde ME. Controversial Issues Regarding Positive Bone Margins in Surgery for Diabetic Foot Osteomyelitis: A Pilot Study. The international journal of lower extremity wounds 2024. link 9 Molines-Barroso RJ, García-Morales E, Sevillano-Fernández D, García-Álvarez Y, Álvaro-Afonso FJ, Lázaro-Martínez JL. Culture Concordance in Different Sections of the Metatarsal Head: Interpretations of Microbiological Results. The international journal of lower extremity wounds 2023. link 10 Chatzipapas C, Kougioumtzis IE, Karaglani M, Panagopoulos P, Panopoulou M, Papazoglou D et al.. Local Antibiotic Delivery Systems in the Surgical Treatment of Diabetic Foot Osteomyelitis: Again, No Benefit?. The international journal of lower extremity wounds 2022. link 11 Iacopi E, Pieruzzi L, Goretti C, Piaggesi A. Pilot Experience on the Use of S53P4 Bioactive Glass in the Surgical Management of Diabetic Foot Osteomyelitis. The international journal of lower extremity wounds 2022. link 12 Xu J, Cheng F, Li Y, Zhang J, Feng S, Wang P. Erythrocyte Sedimentation Rate Combined With the Probe-to-Bone Test for Fast and Early Diagnosis of Diabetic Foot Osteomyelitis. The international journal of lower extremity wounds 2021. link 13 Lee HJ, Chin KM, Lee S, Yap HY, Ch'ng JK, Chng SP et al.. Maximally Disfiguring Surgery for Forefoot Osteomyelitis: Time for a Rethink?. The international journal of lower extremity wounds 2020. link 14 Cohen M, Cerniglia B, Gorbachova T, Horrow J. Added value of MRI to X-ray in guiding the extent of surgical resection in diabetic forefoot osteomyelitis: a review of pathologically proven, surgically treated cases. Skeletal radiology 2019. link 15 Tardáguila-García A, Sanz-Corbalán I, Molines-Barroso RJ, Álvaro-Afonso FJ, García-Álvarez Y, Lázaro-Martínez JL. Complications associated with the approach to metatarsal head resection in diabetic foot osteomyelitis. International wound journal 2019. link 16 van Asten SA, Jupiter DC, Mithani M, La Fontaine J, Davis KE, Lavery LA. Erythrocyte sedimentation rate and C-reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis. International wound journal 2017. link 17 Ashong CN, Raheem SA, Hunter AS, Mindru C, Barshes NR. Methicillin-Resistant Staphylococcus aureus in Foot Osteomyelitis. Surgical infections 2017. link 18 van Asten SA, La Fontaine J, Peters EJ, Bhavan K, Kim PJ, Lavery LA. The microbiome of diabetic foot osteomyelitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2016. link 19 Zeun P, Gooday C, Nunney I, Dhatariya K. Predictors of Outcomes in Diabetic Foot Osteomyelitis Treated Initially With Conservative (Nonsurgical) Medical Management: A Retrospective Study. The international journal of lower extremity wounds 2016. link 20 Aragón-Sánchez J, Lázaro-Martínez JL, Alvaro-Afonso FJ, Molinés-Barroso R. Conservative Surgery of Diabetic Forefoot Osteomyelitis: How Can I Operate on This Patient Without Amputation?. The international journal of lower extremity wounds 2015. link 21 Tone A, Nguyen S, Devemy F, Topolinski H, Valette M, Cazaubiel M et al.. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes care 2015. link 22 Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Molecular imaging and biology 2010. link 23 Shank CF, Feibel JB. Osteomyelitis in the diabetic foot: diagnosis and management. Foot and ankle clinics 2006. link 24 Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M et al.. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006. link 25 Chan MK, Chong LY. A prospective epidemiologic survey on the prevalence of foot disease in Hong Kong. Journal of the American Podiatric Medical Association 2002. link 26 Senneville E, Yazdanpanah Y, Cazaubiel M, Cordonnier M, Valette M, Beltrand E et al.. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. The Journal of antimicrobial chemotherapy 2001. link 27 Ha Van G, Siney H, Danan JP, Sachon C, Grimaldi A. Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery. Diabetes care 1996. link

Osteomyelitis of foot